The pathogenesis of MASLD may encompass the involvement of lysosomal acid lipase (LAL), an enzyme that breaks down triglycerides and cholesteryl esters in various hepatic cells and monocyte-macrophages produced from bone marrow [97]. Here, LIPA is linked to metabolic dysfunction-associated steatotic liver disease.